Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQXT.L Regulatory News (QXT)

  • There is currently no data for QXT

Board Appointment

20 Jun 2016 07:00

RNS Number : 6177B
Quixant PLC
20 June 2016
 

Quixant plc

("Quixant" or the "Company")

 

Board Appointment

 

Quixant (AIM: QXT), a leading provider of specialised computing platforms and monitors for gaming and slot machine applications, is pleased to announce the appointment of Jon Jayal to the Board as Chief Operating Officer.

 

Jon was one of the founders of Quixant in 2005 and helped to design the Company's first product. Following a period working in the investment industry with Mercer and BlackRock, he re-joined Quixant in 2012 as General Manager and is a Director of Quixant UK Ltd. Jon is a Chartered Financial Analyst.

 

Nick Jarmany, CEO of Quixant, commented: "I am delighted that Jon is joining the Board. His understanding of our market, products, technology and customers coupled with his knowledge of the City makes him an invaluable member of our team. Having created and managed the implementation of many of our systems and processes Jon has a deep understanding of the company. I have no doubt that our Board is strengthened by his appointment."

 

The following information regarding Jonathan Francis Jayal, aged 34, is required to be disclosed under Schedule 2(g) of the AIM Rules for Companies:

 

Other directorships held:

 

Current:

Within the last five years:

Quixant UK Limited

Densitron Technologies Limited

nil

 

Mr Jayal holds 510,200 options over ordinary shares of 0.1 pence in the capital of the Company.

 

There are no further disclosures to be made under Schedule 2(g) of the AIM Rules.

 

For further information please contact:

 

Quixant plc

Tel: +44 (0)1223 892696

Nick Jarmany, Chief Executive

 

 

 

 

Nominated Adviser and Broker:

Tel: +44(0)20 7220 0500

finnCap

Matt Goode / Grant Bergman (Corporate Finance)

 

 

 

Simon Johnson / Alice Lane (Corporate Broking)

 

 

 

Financial PR:

 

Alma PR

 

John Coles

Tel: +44 (0)7836 273660

Hilary Buchanan

Tel: +44 (0)7515 805218

 

About Quixant

Quixant, founded in 2005, designs and manufactures complete advanced hardware and software solutions (Gaming Platforms) for the pay-for-play gaming and slot machine industry. The Company is headquartered in Balsham, just outside of Cambridge in the UK. Quixant UK Ltd is responsible for the Group's global (excluding North America) sales function and its Las Vegas based subsidiary, Quixant USA Inc, is responsible for sales and sales support to the North American market. Quixant has its own manufacturing and engineering operation in Taiwan, which has evolved with the rapid growth of the Company. Quixant's Italian subsidiary, Quixant Italia srl, houses the Group's software engineering and customer support team. Quixant Deutschland GmbH is a centre of excellence for Quixant's gaming monitor products.

 

Quixant's high quality, specialised products provide an all-in-one solution, based on PC technology but with augmentative hardware features and operating software developed specifically to address the requirements of the gaming industry. Products feature innovative mechanical designs which are optimised for operation in the gaming and slot machine environment. Quixant's proprietary hardware and embedded software is flexible in its design, enabling Quixant to easily respond to changes in regulation or customers operating in different markets or jurisdictions.

 

In November 2015 Quixant acquired Densitron Technologies plc. Densitron has a strong heritage in the sale of electronic display solutions to global industrial markets. Through Densitron's experienced global sales team, Quixant has a robust platform to deliver its computer products to industrial markets outside gaming.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAGGUPPQUPQPUR
Date   Source Headline
11th Jun 20193:00 pmRNSHolding(s) in Company
21st May 20194:39 pmRNSHolding(s) in Company
3rd May 201911:07 amRNSDirector/PDMR Shareholding
1st May 20194:09 pmRNSGrant of Options
1st May 20194:03 pmRNSExercise of Options
18th Apr 20194:49 pmRNSExercise of Options
16th Apr 201911:13 amRNSResult of AGM
10th Apr 20197:00 amRNSDirector/PDMR Shareholding
4th Apr 20195:57 pmRNSGrant of Options
4th Apr 20191:54 pmRNSGrant of Options
27th Mar 20197:00 amRNSDirector/PDMR Shareholding
25th Mar 20197:00 amRNSFinal Results
24th Jan 20197:00 amRNSTrading Update and Notice of Results
21st Jan 20192:51 pmRNSHolding(s) in Company
4th Jan 201910:13 amRNSBoard Change
22nd Oct 20189:41 amRNSIssue of Equity & PDMR Dealing
5th Oct 20185:50 pmRNSIssue of Options & Director/PDMR Dealings
21st Sep 20187:40 amRNSHolding(s) in Company
19th Sep 20187:00 amRNSHalf-year Report
19th Jul 20187:00 amRNSTrading Update and Notice of Results
4th Jul 20184:36 pmRNSDirector/PDMR Shareholding
14th May 20188:07 amRNSHolding(s) in Company
11th May 20184:10 pmRNSDirector/PDMR Dealings
30th Apr 20187:00 amRNSDirector/PDMR Shareholdings
27th Apr 20182:15 pmRNSResult of placing in Quixant plc
27th Apr 20189:50 amRNSProposed placing in Quixant plc
24th Apr 201811:14 amRNSResult of AGM
5th Apr 20183:23 pmRNSGrant of Options
26th Mar 20184:18 pmRNSDividend Timetable
22nd Mar 20187:00 amRNSFinal Results
1st Mar 20187:00 amRNSBoard Changes and Appointment of CFO
2nd Feb 201810:08 amRNSHolding(s) in Company
25th Jan 20187:00 amRNSTrading Update and Notice of Results
28th Nov 20171:59 pmRNSDirector/PDMR Shareholding
27th Oct 20175:15 pmRNSIssue of Equity and Director/PDMR Shareholding
4th Oct 20172:23 pmRNSHolding(s) in Company
21st Sep 20177:03 amRNSHolding(s) in Company
21st Sep 20177:00 amRNSHalf-year Report
11th Sep 20173:00 pmRNSHolding(s) in Company
22nd Aug 201710:16 amRNSHolding(s) in Company
7th Aug 20177:00 amRNSNotice of Results
24th Jul 20177:00 amRNSTrading Update and Notice of Results
13th Jul 201710:25 amRNSHolding(s) in Company
2nd Jun 20178:00 amRNSDirector/PDMR Shareholding
12th May 20174:55 pmRNSDirector/PDMR Shareholding
4th May 20172:37 pmRNSIssue of Equity and Director/PDMR Dealings
25th Apr 201712:15 pmRNSResult of AGM
22nd Mar 201712:00 pmRNSBoard Appointment
22nd Mar 201710:00 amRNSDividend Timetable
22nd Mar 20177:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.